<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01520415</url>
  </required_header>
  <id_info>
    <org_study_id>AEPMU-01</org_study_id>
    <nct_id>NCT01520415</nct_id>
  </id_info>
  <brief_title>Clinical Trial Examining the Short and Long-term Effect of Myofascial Trigger Points Injection in Low Back Pain Patients</brief_title>
  <official_title>A Prospective, Randomized, Double-blind, Clinical Trial of Trigger Point Injection Therapy for the Treatment of Myofascial Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Yoram Shir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to examine the short and long-term effect of myofascial
      trigger point injections with either a local anesthetic or saline in patients with chronic
      low back pain presenting with myofasical pain syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure pain threshold of the myofascial trigger points</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in the pressure pain threshold will be measured using a pressure algometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pressure pain threshold of MTPs</measure>
    <time_frame>baseline, 4 weeks, 8 weeks</time_frame>
    <description>Change in the pressure pain threshold of MTPs after each MTP injection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Low Back Pain</measure>
    <time_frame>baseline, 4 weeks, 8 weeks, 12 weeks</time_frame>
    <description>Change in pain intensity after each MTPI and at the end of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roland-Morris Disability Questionnaire (RDQ-20)</measure>
    <time_frame>baseline, 4 weeks, 8 weeks, 12 weeks</time_frame>
    <description>Change in disability levels after each MTPI and at the end of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-Form Health Status Survey 12 (SF-12)</measure>
    <time_frame>baseline, 4 weeks, 8 weeks, 12 weeks</time_frame>
    <description>Change in functional status, well-being and quality of life after each MTPI and at the end of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesic medications</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in the consumption of analgesic medications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with Adverse Events</measure>
    <time_frame>12 weeks</time_frame>
    <description>Adverse events resulting from the intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit</description>
    <arm_group_label>bupivacaine</arm_group_label>
    <other_name>lidocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>2ml per injection up to a maximum of 8ml (4 identified trigger points) per visit</description>
    <arm_group_label>saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CLBP of non-malignant origin, with or without accompanying leg pain, including
             patients with history of previous back surgery or trauma

          -  MPS as evident by at least one active MTP, located medial or lateral to the posterior
             iliac crest involving the gluteus maximus or medius, quadratus lumborum and erector
             spinae muscles

          -  While not precluding the participation in the study, MTP in other areas will not make
             patients eligible

          -  Pain lasting for at least six months

        Exclusion Criteria:

          -  Any current motor weakness, but not sensory loss or abnormal reflexes in the lower
             limbs

          -  Any injection or nerve block in the low back in the last 6 months

          -  Local or systemic infection

          -  Bleeding disorder or the use of anticoagulation medications

          -  Known allergy to local anesthetics

          -  Poor understanding of written and spoken English or French
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoram Shir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUHC-RI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alan Edwards Pain Management Unit - Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2012</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2012</study_first_posted>
  <last_update_submitted>July 26, 2013</last_update_submitted>
  <last_update_submitted_qc>July 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Dr. Yoram Shir</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

